Renal-limited ANCA-associated vasculitis during erlotinib treatment for lung carcinoma

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) had clinical success in the treatment of non-small cell lung carcinoma (NSCLC). An effect of this drug on kidney has not been clarified and the occurrence of glomerulonephritis related to EGFR-TKI has rarely been reported. We pr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	CEN case reports 2022-02, Vol.11 (1), p.67-72
Hauptverfasser:	Oki, Rikako, Hirakawa, Yosuke, Oda, Yasuhiro, Nakamura, Motonobu, Honda, Kenjiro, Abe, Hiroyuki, Domoto, Yukako, Miyashita, Naoya, Nagase, Takahide, Nangaku, Masaomi
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - chemically induced Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - diagnosis Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy Carcinoma - drug therapy Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - pathology Case Report ErbB Receptors Erlotinib Hydrochloride - adverse effects Female Glomerulonephritis - chemically induced Glomerulonephritis - diagnosis Glomerulonephritis - drug therapy Hematuria - chemically induced Humans Kidney - pathology Lung Lung Neoplasms - drug therapy Lung Neoplasms - pathology Male Medicine Medicine & Public Health Nephrology Protein Kinase Inhibitors - adverse effects Proteinuria - drug therapy Urology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!